trending Market Intelligence /marketintelligence/en/news-insights/trending/n2vvJzZnuB4ZaATZQNxHtg2 content esgSubNav
In This List

Fitch affirms Amgen's long-term issuer default rating

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Fitch affirms Amgen's long-term issuer default rating

Fitch Ratings affirmed Amgen Inc.'s long-term issuer default rating at BBB.

The outlook on the rating is stable.

The ratings apply to $36.7 billion of debt outstanding at Sept. 30.

Fitch said Amgen's BBB rating reflects the smaller and less diversified nature of the company's operating profile comparative to larger innovative industry peers, Pfizer Inc. and Merck & Co. Inc.